Sesen Bio Inc (SESN)

[voisybay123]

SESN has more than enough to get to approval and commercialization--the ATM in January was $55 million--and there will be more money coming from partnerships (likely Europe this time)--no AdCOM, PDUFA now August 18--this will get approval--the only question is whether either Merck or Astra Zeneca will buyout SESN or in the least form a strategic partnership--Merck markets Keytruda and Vicinium will be preferred for NMIBC over Keytruda due to its far less side effect profile so I suspect it will be Merck making an offer (or even better a "bidding war" after approval)